Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2003
12/11/2003US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders
12/11/2003US20030229208 Humanized immunoglobulins
12/11/2003US20030229206 Processing albumin via grinding substance to flour, alkaline and protease extractions, heating, precipitation, neutralization and recovery
12/11/2003US20030229204 PCG-1, a novel brown fat PPARgamma coactivator
12/11/2003US20030229021 Antiallergens
12/11/2003US20030228709 Arrays
12/11/2003US20030228696 Novel insect cell line
12/11/2003US20030228673 Novel glucose 6-oxidases
12/11/2003US20030228671 Fermenting lactic acid in kluyveromyces for use in cosmetics, pharmaceuticals, plastics and food production
12/11/2003US20030228664 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2003US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders
12/11/2003US20030228660 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
12/11/2003US20030228658 Comprises nucleotide sequences coding membrane protein for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating melanomas, pigmentation disorders and inflammation; forensics; drug screening
12/11/2003US20030228657 Methods for enhancing the translation and expression of recombinant proteins
12/11/2003US20030228656 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2003US20030228655 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2003US20030228654 Method for producing antimicrobial protein and fusion protein
12/11/2003US20030228653 Novel orphan cytokine receptor polypeptides
12/11/2003US20030228640 Using early prostate antigen as tool in diagnosis, prognosis and treatment of cancer
12/11/2003US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof
12/11/2003US20030228593 Ribozymes with broad tRNA aminoacylation activity
12/11/2003US20030228329 Genetic engineering; insertion of gene; generating immunology response
12/11/2003US20030228319 Antitumor agents, anticancer agents
12/11/2003US20030228316 Mitochondrial creatine kinase antibody
12/11/2003US20030228305 Compositions and methods for the diagnosis and treatment of tumor
12/11/2003US20030228303 Antibodies specific for native PrPsc
12/11/2003CA2491420A1 Rb1 gene induced protein (rb1cc1) and gene
12/11/2003CA2488547A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/11/2003CA2488539A1 Novel proteins and nucleic acids encoding same
12/11/2003CA2488196A1 Methods and materials for the production of lactic acid in yeast
12/11/2003CA2487932A1 Cd16a binding proteins and use for the treatment of immune disorders
12/11/2003CA2487915A1 Allergen from mugwort pollen
12/11/2003CA2487296A1 Methods and materials for the production of d-lactic acid in yeast
12/11/2003CA2487024A1 Control sequences of the human corin gene
12/10/2003EP1369487A2 Recombinant vectors derived from adenovirus for use in gene therapy
12/10/2003EP1369486A1 Plasmid shuttle vector between escherichia coli and brevibacillus
12/10/2003EP1369483A1 Allergen from mugwort pollen
12/10/2003EP1369481A1 Novel translational activity-promoting higher-order structure
12/10/2003EP1369478A1 Novel scavenger receptor class a protein
12/10/2003EP1369431A1 Anti-hla-dr antibody
12/10/2003EP1369430A2 Two human G-Protein coupled receptors: EBV-induced GPCR 2(EBI-2) and EBG-1-like GPCR
12/10/2003EP1369427A2 HIV-3 retrovirus strains and their use
12/10/2003EP1368659A2 Subunit vaccines with a2 supermotifs
12/10/2003EP1368486A2 Formulations for il-11
12/10/2003EP1368483A2 Process for production of polypeptides
12/10/2003EP1368477A1 Vaccine
12/10/2003EP1368476A2 Rearranged squamous cell carcinoma antigen genes ii
12/10/2003EP1368474A1 Polynucleotide useful for modulating cancer cell proliferation
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation
12/10/2003EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/10/2003EP1368459A2 Influenza viruses with enhanced transcriptional and replicational capacities
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368456A2 Anti-bacterial vaccine compositions
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368377A2 Modified interferon beta with reduced immunogenicity
12/10/2003EP1368051A2 Urocortin-iii and uses thereof
12/10/2003EP1367881A2 Plant cell having animal-type sugar chain adding function
12/10/2003EP1123410B1 The enzyme-mediated synthesis of peptidomimetics
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/10/2003EP0912611B1 Human monoclonal antibodies to the hepatitis b surface antigen
12/10/2003EP0824589B1 Utrophin gene promoter
12/10/2003EP0770139B1 A FUNGUS WHEREIN THE areA GENE HAS BEEN MODIFIED AND AN areA GENE FROM ASPERGILLUS ORYZAE
12/10/2003EP0754059B1 Methods and compositions useful for inhibition of angiogenesis
12/10/2003EP0724641B1 Anti-microbial proteins
12/10/2003EP0724456B1 Antibodies to cd40
12/10/2003EP0680316B1 Novel parasitic helminth proteins
12/10/2003EP0671920B1 An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0502892B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
12/10/2003CN1461344A Multivalent target binding protein
12/10/2003CN1461343A 多核苷酸 Polynucleotide
12/10/2003CN1461342A Glycosylated VEGF-B and method for increasing amount of soluble VEFG-B
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461309A Inhibitory PAS domain protein (IPAS) and screening methods related to angiogenesis and tumor progression
12/10/2003CN1460714A Cell activation and adverse-resisting gene inductor and its prepartion method
12/10/2003CN1130463C Fermentation precess by expressing recombined protein in bacillus
12/10/2003CN1130374C Synthetic peptide analogs of lung surfactant protein SP-C
12/10/2003CN1130221C Use of glial neurotrophic factor (GDNF) for treatment of hearing disorders
12/09/2003US6660905 Mice comprising engrafted functional human hepatocytes
12/09/2003US6660848 Signal Transducer and Activator of Transcription (STAT) proteins are a new class of intracellular transcription factors
12/09/2003US6660843 Fusion of Fc domains with biologically active peptides
12/09/2003US6660839 Tumor necrosis related receptor, TR7
12/09/2003US6660834 Reagents useful for detecting diseases of the gastrointestinal tract
12/09/2003US6660523 Propagating preferential nervous system tissues; obtain tissue, incubate with preferential antigens, culture tissue, recover tissue
12/09/2003US6660520 Nrde
12/09/2003US6660512 Human lysozyme gene, it's encoded polypeptide and the method of preparing them
12/09/2003US6660501 Production of proteins by cell culture
12/09/2003US6660499 Nucleic acid encoding human DCR5, a protein related to DAN (Differential-screening-selected gene Aberrative in Neuroblastoma)
12/09/2003US6660490 Nucleotide seqences coding enzymatic polypeptide for use in the treatment of cardiovascular disorders
12/09/2003US6660275 Amplification nucleic acids
12/09/2003US6660274 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
12/09/2003US6660271 Ubiquitin fusion-based vaccine system
12/09/2003US6660269 Canine tropical pancytopenia;
12/09/2003US6660263 Mono-chlorinated lipophilic macrocyclic lactone isolated from a strain of Serratia marcescens that produces oocydin A in culture.
12/09/2003US6660257 Flt-3 receptor agonist proteins; nucleic acid sequence
12/09/2003CA2202075C Analogs of keratinocyte growth factor, nucleic acids encoding such analogs, processes of making and methods of using
12/09/2003CA2104110C Nucleic acid fragment from the chromosome x region involved in the fragile x syndrome, nucleotide probe and method for the diagnosis of mental retardation with fragile x
12/04/2003WO2003100082A2 Methods of determining precise herg interactions and altering compounds based on said interactions
12/04/2003WO2003100022A2 Methods and dna constructs for high yield production of polypeptides